We serve Chemical Name:Methyl 3-(bromomethyl)-4-cyanobenzoate CAS:908562-25-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methyl 3-(bromomethyl)-4-cyanobenzoate
CAS.NO:908562-25-4
Synonyms:or2661
Molecular Formula:C10H8BrNO2
Molecular Weight:254.08000
HS Code:2926909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:368.7ºC at 760 mmHg
Density:1.53g/cm3
Index of Refraction:1.575
PSA:50.09000
Exact Mass:252.97400
LogP:2.23978
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like or2661 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,or2661 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,or2661 Use and application,or2661 technical grade,usp/ep/jp grade.
Related News: An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant. Methyl 3-(bromomethyl)-4-cyanobenzoate manufacturer At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival. Methyl 3-(bromomethyl)-4-cyanobenzoate supplier The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances. Methyl 3-(bromomethyl)-4-cyanobenzoate vendor Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. Methyl 3-(bromomethyl)-4-cyanobenzoate factory At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival.
